ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.645,58
-0,08%
S&P 500
5.048,42
-0,46%
US Dollar vs BRL
5,16
0,00%
Bitcoin
64.358,83
-0,20%
Brent Oil
88,305
0,18%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Notícias

TEVA Teva Pharmaceutical Industries Ltd

13,30
0,29 (2,23%)
25 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Teva Pharmaceutical Industries Ltd TEVA NYSE Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,29 2,23% 13,30 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
12,76 12,76 13,30 13,25 13,01
mais cotações »

Notícias Recentes

Data Hora Fonte Título
16/04/202418:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/04/202418:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/04/202409:00BWTeva’s New Real-World Evidence Presented at the 2024 AAN..
11/04/202409:30BWTeva Confirms Efficacy and Safety of AJOVY® (fremanezumab)..
09/04/202417:30BWTeva to Host Conference Call to Discuss First Quarter 2024..
06/04/202414:00BWNew Pharmacokinetic Modeling Data Presented by Teva..
04/04/202409:30BWTeva and mAbxience Announce Strategic Global Licensing..
01/04/202409:30BWClinical Collaboration Agreement between Teva and Launch..
26/02/202409:00BWTeva and Jiangsu Nhwa Forge Strategic Partnership to Promote..
23/02/202422:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
23/02/202422:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
20/02/202410:30BWTeva Presents New Data Supporting Safety, Tolerability and..
13/02/202411:05IHMARKETNEWSHotter-Than-Expected Inflation Data Likely To Weigh On Wall..
12/02/202419:03IHMARKETNEWSDow Reaches New Record Closing High But Nasdaq, S&P 500 Give..
12/02/202411:13IHMARKETNEWSTeva Pharmaceutical, Urban Outfitters Upgraded
31/01/202409:00BWTeva Reports Growth in Fourth Quarter and Full Year 2023
31/01/202408:00BWTeva Announces Intention to Divest API Business as Part of..
02/01/202418:30BWTeva to Host Conference Call to Discuss Fourth Quarter and..
02/01/202410:50DJNCorcept Therapeutics Shares Slide Premarket on Loss in Teva..
28/12/202318:30BWTeva to Present at the 42nd Annual J.P. Morgan Healthcare..
14/12/202310:30BWTeva and Biolojic Design Announce Exclusive License..
06/12/202313:19BWNeue Post-Hoc-Analyse von Phase-3-Daten zeigt, dass AJOVY®..
06/12/202311:24BWUne nouvelle analyse post hoc des données de phase 3 montre..
06/12/202304:00BWNew Post Hoc Phase 3 Data Analysis Shows AJOVY®..
30/11/202311:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
30/11/202310:30BWTeva Completes Closing of Exclusive Collaboration Deal to..
20/11/202318:30BWTeva to Present at the 6th Annual Evercore ISI HealthCONx..
17/11/202310:30BWTeva Announces Approval of a Generic Version of Forteo®..
13/11/202310:10GLOBERoyalty Pharma and Teva Collaborate to Further Accelerate..
13/11/202310:00BWTeva and Royalty Pharma Collaborate to Further Accelerate..
08/11/202309:00BWTeva Reports Third Quarter 2023 Financial Results and..
07/11/202318:30BWTeva appoints new CEO for Teva api, its Active..
02/11/202309:00BWTeva to Present New Data Supporting Safety, Efficacy and..
01/11/202320:31BWUZEDY™ (risperidone) Extended-Release Injectable Suspension..
25/10/202310:00BWTeva to Provide Second Round of Funding to Clinics in..
17/10/202312:51BWTeva UNITE-Studie der Phase IV zeigt: AJOVY® (fremanezumab)..
17/10/202302:30BWTeva Phase IV UNITE Study Shows AJOVY® (fremanezumab)..
06/10/202317:30BWTeva to Host Conference Call to Discuss Third Quarter 2023..
04/10/202302:57DJNSanofi, Teva Collaborate on Inflammatory Bowel Disease Drug
04/10/202302:07BWSanofi and Teva Announce Exclusive Collaboration to Deliver..
28/09/202317:05BWTeva Announces Changes to Executive Management Team
06/09/202317:30BWTeva to Present at the 21st Annual Morgan Stanley Global..
06/09/202309:00BWTeva to Present Data for AUSTEDO® XR (deutetrabenazine)..
22/08/202308:19IHMARKETNEWSTuesday’s Wall Street Highlights: Baidu, Lowe’s, American..
21/08/202317:00BWTeva Settles Price Fixing Charges With U.S. DOJ
03/08/202308:33IHMARKETNEWSThursday’s Wall Street Highlights: Anheuser-Busch InBev,..
02/08/202308:00BWTeva Reports Second Quarter 2023 Financial Results
27/07/202309:00BWTeva Announces Appointment of Dr. Angus Grant to Executive..
24/07/202305:00BWTeva Pharmaceuticals and Alvotech Provide Update on..
05/07/202317:30BWTeva to Host Conference Call to Discuss Second Quarter 2023..

Seu Histórico Recente

NYSE
TEVA
Teva Pharmaceutical Indu...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados